Dr Pecchia was invited to give an invited talk on Health Technology Assessment of medical devices in a panel organized by Prof Tammy Clifford, Vice-President of the Canadian Agency of Technology Assessment (CADTH). Approaches to the assessment of medical devices differs from that for drugs, and also differs across the various phases of the technology lifecycle. This session showcased several recent initiatives that support a lifecycle approach to technology assessment, and highlight linkages to HTA.
The first, organized by Prof Rosanna Tarricone, Associate Dean for Government, Health and Not for Profit Division of the SDA Bocconi School of Management (Bocconi University, Milano), aimed to provide a comprehensive overview of the specific challenges of current HTA of medical devices, discuss how the current regulatory scenario is likely to change in the near future, and disentangle the potential impact on access to valuable medical technologies.
Dr Pecchia has been invited to give a talk titled “HTA of medical devices: Challenges in design and adoption” at the Health Technology Assessment workshop during the Africa Health in Johannesburgh,
Why, differently from the USA, the European Horizon 2020 does not have a dedicated space for BME? Do we want to lag behind USA and Japan in inventing the future of medicine? With this question in mind, MPs Lara Comi (EPP) and Nicola Caputo (S&D) tabled a Parliamentary question written in collaboration with IFMBE HTAD and EAMBES
The 21st of October 2016, the School of Engineering and the ABSPIE will contribute to the first IFMBE Clinical Engineering Global Day (#GlobalCEDay) broadcasting worldwide the Seminar of Prof Dan Clark, titled “Healthcare Technology Innovation & the Future”.
The Seminar will be broadcasted using Webex. Those interested can login for free here:
PhD scholarship: Health Technology Assessment of medical devices for low and middle income countries
Project Overview: Health technologies are changing the model of care. In particular, medical devices are the main enablers of modern medicine. Several methods have been proposed to support political decisions regarding medical device in developed countries. Those methods are far from being perfect and are mainly the result of adaptation of methods, developed mainly for drugs, which fail to consider important dimensions that are relevant for medical devices. However, much less has been don for low and middle income countries. For instance, available economic evaluations of medical devices come predominantly from high income countries, and relevant methods and studies are urgently required in less resourced settings…